SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial

Long-term effects, safety and tolerability of oral semaglutide (SEMA; a GLP-1 receptor agonist [GLP-1RA]) vs sitagliptin (SITA) as add-on to metformin ± sulfonylurea was investigated in patients (pts) with T2D in a 78-week, double-blind, double-dummy trial. Pts were randomized to once daily oral SEM...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, Julio, Allison, Dale, Birkenfeld, Andreas, Blicher, Thalia, Deenadayalan, Srikanth, Jacobsen, Jacob, Serusclat, Pierre, Violante, Rafael, Watada, Hirotaka, Davies, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552181/
http://dx.doi.org/10.1210/js.2019-SAT-139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552181/
http://dx.doi.org/10.1210/js.2019-SAT-139

Ejemplares similares